• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS POWERPORT CLEARVUE SLIM ISP, 8FR; IMPLANTABLE PORT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS POWERPORT CLEARVUE SLIM ISP, 8FR; IMPLANTABLE PORT Back to Search Results
Model Number 5608062
Device Problems Suction Problem (2170); Defective Component (2292)
Patient Problems Ecchymosis (1818); Hematoma (1884); Pain (1994)
Event Date 12/18/2019
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.(expiration date: 03/2020); (b)(4).
 
Event Description
It was reported that approximately one day post port device implant, the patient allegedly developed a pocket hematoma.It was further reported that as a result of the hematoma, the physician deemed to removed the port.Prior to removing the port, healthcare providers accessed the port, infused with sterile saline, noticed sluggish flow, and swelling and pain of the port site.The physician then removed the port device and the patient did not experience any new symptoms.A temporary peripheral central venous catheter was inserted for chemotherapy to allow the port site tissue to heal.Additionally, upon removal, the silicone septum was allegedly noted to have a level of air/fluid; however, the port and catheter tubing were intact and no tubing leaks were identified.The patient was reported as stable and was discharged after the remove procedure.
 
Event Description
It was reported that approximately one day post port device implant, the patient allegedly developed a pocket hematoma.It was further reported that as a result of the hematoma, the physician deemed to removed the port.Prior to removing the port, healthcare providers accessed the port, infused with sterile saline, noticed sluggish flow, and swelling and pain of the port site.The physician then removed the port device and the patient did not experience any new symptoms.A temporary peripheral central venous catheter was inserted for chemotherapy to allow the port site tissue to heal.Additionally, upon removal, the silicone septum was allegedly noted to have a level of air/fluid; however, the port and catheter tubing were intact and no tubing leaks were identified.The patient was reported as stable and was discharged after the remove procedure.
 
Manufacturer Narrative
H10: manufacturing review: the lot met all release criteria.The device history was reviewed and no deviations/issues were identified associated with this problem in regards to product materials or during packaging, manufacturing or quality control inspection processes.All necessary inspections were performed throughout all the manufacturing, packaging and inspection activities and for raw material utilized in the manufacture of this lot, in regards to the described problem.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the ifu instructs on port implantation and accessing the port to conduct flow studies.Therefore, the product labeling will be considered adequate.Investigation summary: one powerport clearvue with attached catheter was returned for evaluation.Functional, gross visual, microscopic visual and tactile evaluations were performed.The investigation is inconclusive for slow flow and air/fluid in port septum.The returned sample was found to be freely patent to infusion and aspiration, no leaks were observed under hydraulic, and no anomalies were identified in the returned sample.However, the exact circumstances at the time of the reported event could not be recreated during the sample evaluation.The definitive root cause could not be determined based upon available information.H10:g4 h11: h3, h6 (method, results, conclusion, patient: 2091).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT CLEARVUE SLIM ISP, 8FR
Type of Device
IMPLANTABLE PORT
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
MDR Report Key9588902
MDR Text Key175031253
Report Number3006260740-2019-04130
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027369
UDI-Public(01)00801741027369
Combination Product (y/n)N
PMA/PMN Number
K122899
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 05/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number5608062
Device Catalogue Number5608062
Device Lot NumberREDP4678
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/30/2019
Date Manufacturer Received05/07/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient Weight73
-
-